By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A consortium of researchers in Europe have received a grant of nearly €6 million ($8.4 million) from the EU to fund studies of two breast cancer types that are difficult to treat and amount to one quarter of all breast cancer cases: invasive lobular carcinoma and triple-negative breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.